Article: Hong Kong : Lijun International (HKG:2005) Subsidiary Shijiazhuang No.4 Pharma Successfully Developed Enerxin Capsule, An Effective Restraint Of The Growth Of Inf.

Article: Lijun International (HKG:2005) Subsidiary ...
abnnewswire.net;  November 9, 2009 ;     700+ words ...Lijun International Pharmaceutical ... announce that Enerxin Capsule, which is ... showed that Enerxin Capsule had an obvious ... function of Enerxin Capsule on the block ... biosynthesis. About Lijun International Pharmaceutical ...

Article: Lijun International Pharmaceutical Announcement of ...
ACN Newswire;  July 17, 2009 ;     700+ words ... ... 2009 - (ACN Newswire) - Lijun International Pharmaceutical (Holding) Co., Ltd. ("Lijun International" or the "Company"; stock ... Mr. Wu Qin, Chairman of Lijun International said: "Despite the global ...

Article: LIJUN INTERNATIONAL TO BUY SHIJIAZHUANG NO.4 ...
AsiaInfo Services;  April 5, 2007 ;     335 words ... ... AsiaInfo Services 04-05-2007 Lijun International to Buy Shijiazhuang No.4 Pharmaceutical ... 2007 (SinoCast via COMTEX) -- Lijun International Pharmaceutical (Holding) Co ... be a wholly-owned subsidiary of Lijun International after the acquisition. It used ...

Article: Mainland firms prepare for HK listing
China Daily;  December 14, 2005 ;     521 words ... ... power meters maker Wasion Meters. Also due to debut are Xiamen International Port, pharmaceutical manufacturer Lijun International and Guangzhou Investment Real Estate Investment Trust (GZI REIT). Among them, Tang said, two property stocks ...

Article: Beijing's soft power in Southeast Asia China and its neighbors
International Herald Tribune;  January 18, 2007 ;     683 words ...Sheng Lijun International Herald Tribune 01-18-2007 China's diplomatic successes in Southeast Asia have often come about through skilful exploitation ...

Article: Lijun to acquire Shijiazhuang No. 4 Pharma.
China Business News;  April 3, 2007 ;     583 words ...Lijun to acquire Shijiazhuang No. 4 Pharma Shanghai. April 3. INTERFAX-CHINA - Lijun International Pharmaceutical Ltd. has signed and agreement to acquire New Orient Group, enabling it to take control of one of China's leading ...

Article: HONG KONG NEWSPAPER HIGHLIGHTS - MARCH 21, 2006.
AsiaPulse News;  March 21, 2006 ;     700+ words ... ... when it introduces by phases cheaper and cleaner natural gas. - Two Hong Kong-listed mainland drugmakers, Lijun International Pharmaceutical (Holding) and China Shineway Pharmaceutical Group, reported net profit growth in 2005. - China ...